Advanced search
Publication Cover
Gynecological Endocrinology Volume 37, 2021 - Issue 4
Submit an article Journal homepage
2,582
Views
12
CrossRef citations to date
0
Altmetric
PREMATURE OVARIAN FAILURE

Human umbilical cord mesenchymal stem cells (hUCMSCs) promotes the recovery of ovarian function in a rat model of premature ovarian failure (POF)

Xunyi ZhangReproductive Medicine Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaView further author information
,
Lina ZhangReproductive Medicine Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaView further author information
,
Ying LiReproductive Medicine Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaView further author information
,
Zhe YinReproductive Medicine Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaView further author information
,
Yun FengReproductive Medicine Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Yazhong JiReproductive Medicine Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaCorrespondence[email protected]
View further author information
Pages 353-357 | Received 10 Jul 2020, Accepted 07 Nov 2020, Published online: 25 Jan 2021

References

  • Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604–606.
  • Wu XY, Cai H, Kallianpur A, et al. Impact of premature ovarian failure on mortality and morbidity among chinese women. PLoS One. 2014;9(3):e89597.
  • Jankowska K. Premature ovarian failure. Prz Menopauzalny. 2017;16(2):51–56.
  • Fu L, Feng W, Li SR, et al. ZP3 peptides administered orally suppress murine experimental autoimmune ovarian disease. J Reprod Immunol. 2007;75(1):40–47.
  • Rhim SH, Millar SE, Robey F, et al. Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida. J Clin Invest. 1992;89(1):28–35.
  • Sassarini J, Lumsden MA, Critchley HO. Sex hormone replacement in ovarian failure – new treatment concepts. Best Pract Res Clin Endocrinol Metab. 2015;29(1):105–114.
  • Slopien R, Warenik-Szymankiewicz A. Premature ovarian failure: diagnosis and treatment. Clin Exp Obstet Gynecol. 2014;41(6):659–661.
  • Ebrahimi M, Asbagh FA. The role of autoimmunity in premature ovarian failure. Iran J Reprod Med. 2015;13(8):461–472.
  • Strong AL, Neumeister MW, Levi B. Stem cells and tissue engineering: regeneration of the skin and its contents. Clin Plast Surg. 2017;44(3):635–650.
  • Vats A, Bielby RC, Tolley NS, et al. Stem cells. Lancet. 2005;366(9485):592–602.
  • Han Y, Li X, Zhang Y, et al. Mesenchymal stem cells for regenerative medicin. Cells. 2019;8(8):886.
  • Chu D-T, Phuong TNT, Tien NLB, et al. An update on the progress of isolation, culture, storage, and clinical application of human bone marrow mesenchymal stem/stromal cells. Int J Mol Sci. 2020;21(3):708.
  • Wang S, Yu L, Sun M, et al. The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure. Biomed Res Int. 2013;2013:690491.
  • Yin N, Zhao W, Luo QQ, et al. Restoring ovarian function with human placenta-derived mesenchymal stem cells in autoimmune-induced premature ovarian failure mice mediated by Treg Cells and associated cytokines. Reprod Sci. 2017;33:193371911773215.
  • Takehara Y, Yabuuchi A, Ezoe K, et al. The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab Invest. 2013;93(2):181–193.
  • Ghadami M, El-Demerdash E, Zhang D, et al. Bone marrow transplantation restores follicular maturation and steroid hormones production in a mouse model for primary ovarian failure. PLoS One. 2012;7(3):e32462.
  • Zhang Z, Feng R, Niu L, et al. Human umbilical cord mesenchymal stem cells inhibit T follicular helper cell expansion through the activation of iNOS in Lupus-Prone B6.MRL-Faslpr mice. Cell Transplant. 2017;26(6):1031–1042.
  • Decot V, El Omar R, Beroud J, et al. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell based therapies? Tissue Eng Part B, Rev. 2014;20(5):523–544.
  • Liu G, Wang L, Pang T, et al. Umbilical cord-derived mesenchymal stem cells regulate thymic epithelial cell development and function in Foxn1(–/–) mice. Cell Mol Immunol. 2014;11(3):275–284.
  • Song D, Zhong Y, Qian C, et al. Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature Ovarian failure rat model. Biomed Res Int. 2016;2016:2517514.
  • Zhang X, Hirai M, Cantero S, et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem. 2011;112(4):1206–1218.
  • Ghannam S, Bouffi C, Djouad F, et al. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther. 2010;1(1):2.
  • Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol. 2002;62(4A):609–614.
  • Zhang L, Tan X, Dong C, et al. In vitro differentiation of human umbilical cord mesenchymal stem cells (hUCMSCs), derived from Wharton’s jelly, into choline acetyltransferase (ChAT)-positive cells. Int J Dev Neurosci. 2012;30(6):471–477.
  • Lu Z, Ye D, Qian L, et al. Human umbilical cord mesenchymal stem cell therapy on neuromyelitis optica. Curr Neurovasc Res. 2012;9(4):250–255.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.